Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 4.2/5
Imeik Technology Development C

Imeik Technology Development C (300896 CH)

59
Analysis
Health CareChina
Imeik Technology Development Co,,Ltd. manufactures and distributes biomedical products. The Company produces sodium hyaluronate, collagens, polylactic acids, and other related products. Imeik Technology Development also produces medical devices.
more
11 Jan 2023 01:50

Aequitas 2023 Asia IPO Pipeline - Hong Kong

In this note, we will take a look at the Asia Pacific IPO pipeline for 2023, starting with Hong Kong. The deals you see are only a part of the...

Logo
588 Views
Share
28 Dec 2022 00:55

Pre-IPO Beauty Farm Medical and Health Industry - Hard to Make Money Due to Industry Characteristics

As a downstream company, Beauty Farm has weak bargaining power in the whole industrial chain.We are conservative about its profitability. The...

Logo
816 Views
Share
bullishGiant Biogene
03 Nov 2022 01:50

Giant Biogene IPO Trading - Demand Was Relatively Better but Still Weak

Giant Biogene (GB) raised around US$70m by pricing its  HK IPO at the low-end. In this note we talk about the trading dynamics.

Logo
327 Views
Share
bullishGiant Biogene
25 Oct 2022 03:17

Giant Biogene IPO - Reasonable Valuation but in Unreasonable Markets

Giant Biogene is now looking to raise around US$80m in its Hong Kong IPO, down from its earlier target of US$500m raising.

Logo
354 Views
Share
bullishGiant Biogene
19 Oct 2022 01:51

Giant Biogene Pre-IPO - Thoughts on Valuation

Giant Biogene Holding (GBH HK) aims to raise around US$500m in its Hong Kong IPO. In this note, we talk about valuations.

Logo
349 Views
Share
x